Huntington National Bank’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15 | Hold |
1
| – | – | ﹤0.01% | 3575 |
|
2025
Q1 | $15 | Sell |
1
-50
| -98% | -$750 | ﹤0.01% | 3602 |
|
2024
Q4 | $675 | Buy |
51
+50
| +5,000% | +$662 | ﹤0.01% | 2453 |
|
2024
Q3 | $14 | Sell |
1
-3,235
| -100% | -$45.3K | ﹤0.01% | 3621 |
|
2024
Q2 | $41.9K | Buy |
3,236
+718
| +29% | +$9.29K | ﹤0.01% | 1185 |
|
2024
Q1 | $35K | Hold |
2,518
| – | – | ﹤0.01% | 1259 |
|
2023
Q4 | $35.9K | Sell |
2,518
-388
| -13% | -$5.54K | ﹤0.01% | 1208 |
|
2023
Q3 | $45K | Buy |
2,906
+334
| +13% | +$5.17K | ﹤0.01% | 1078 |
|
2023
Q2 | $40.4K | Buy |
2,572
+54
| +2% | +$848 | ﹤0.01% | 1128 |
|
2023
Q1 | $41.5K | Sell |
2,518
-1,341
| -35% | -$22.1K | ﹤0.01% | 1073 |
|
2022
Q4 | $60.2K | Buy |
3,859
+1,023
| +36% | +$16K | ﹤0.01% | 928 |
|
2022
Q3 | $37K | Hold |
2,836
| – | – | ﹤0.01% | 1084 |
|
2022
Q2 | $40K | Sell |
2,836
-1,290
| -31% | -$18.2K | ﹤0.01% | 1074 |
|
2022
Q1 | $59K | Buy |
4,126
+1,290
| +45% | +$18.4K | ﹤0.01% | 1007 |
|
2021
Q4 | $39K | Buy |
2,836
+1
| +0% | +$14 | ﹤0.01% | 1150 |
|
2021
Q3 | $46K | Sell |
2,835
-441
| -13% | -$7.16K | ﹤0.01% | 1003 |
|
2021
Q2 | $55K | Buy |
3,276
+759
| +30% | +$12.7K | ﹤0.01% | 923 |
|
2021
Q1 | $46K | Hold |
2,517
| – | – | ﹤0.01% | 883 |
|
2020
Q4 | $46K | Hold |
2,517
| – | – | ﹤0.01% | 842 |
|
2020
Q3 | $45K | Hold |
2,517
| – | – | ﹤0.01% | 821 |
|
2020
Q2 | $45K | Sell |
2,517
-3,255
| -56% | -$58.2K | ﹤0.01% | 822 |
|
2020
Q1 | $88K | Sell |
5,772
-655
| -10% | -$9.99K | ﹤0.01% | 622 |
|
2019
Q4 | $126K | Buy |
6,427
+2,603
| +68% | +$51K | ﹤0.01% | 641 |
|
2019
Q3 | $65K | Sell |
3,824
-2,483
| -39% | -$42.2K | ﹤0.01% | 760 |
|
2019
Q2 | $112K | Sell |
6,307
-280
| -4% | -$4.97K | ﹤0.01% | 635 |
|
2019
Q1 | $134K | Buy |
+6,587
| New | +$134K | ﹤0.01% | 607 |
|